Jim Simons Vbi Vaccines Inc Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.29 - $0.64 $32,760 - $72,298	112,967 Added 16.46%	799,403 $242,000
Q4 2022 Feb 13, 2023	SELL	$0.38 - $22.5 $87,230 - $5.16 Million	-229,554 Reduced 25.06%	686,436 $268,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $92,337 - $2.96 Million	126,490 Added 16.02%	915,990 $647,000
Q2 2022 Aug 12, 2022	BUY	$0.66 - $1.81 $407,484 - $1.12 Million	617,400 Added 358.74%	789,500 $638,000
Q1 2022 May 13, 2022	BUY	$1.27 - $2.47 $218,567 - $425,087	172,100 New	172,100 $286,000
Q3 2020 Nov 13, 2020	SELL	$2.77 - $6.17 $595,273 - $1.33 Million	-214,900 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.87 - $3.13 $111,273 - $400,327	-127,900 Reduced 37.31%	214,900 $666,000
Q1 2020 May 14, 2020	BUY	$0.73 - $1.91 $250,244 - $654,748	342,800 New	342,800 $326,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.